Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Single-cell transcriptome profiling of tumour tissue isolates allows the characterization of heterogeneous tumour cells along with neighbouring stromal and immune cells. Here we adopt this powerful approach to breast cancer and analyse 515 cells from 11 patients. Inferred copy number variations from the single-cell RNA-seq data separate carcinoma cells from non-cancer cells. At a single-cell resolution, carcinoma cells display common signatures within the tumour as well as intratumoral heterogeneity regarding breast cancer subtype and crucial cancer-related pathways. Most of the non-cancer cells are immune cells, with three distinct clusters of T lymphocytes, B lymphocytes and macrophages. T lymphocytes and macrophages both display immunosuppressive characteristics: T cells with a regulatory or an exhausted phenotype and macrophages with an M2 phenotype. These results illustrate that the breast cancer transcriptome has a wide range of intratumoral heterogeneity, which is shaped by the tumour cells and immune cells in the surrounding microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Limited T-cell recruitment and function in the TME correlates with poor prognosis in BC (21,22).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709 · cited 1×
“4.0b (default parameters) 55 , and relative gene expression was quantified as transcript per million (TPM) using RSEM v1.”
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
GSVA: gene set variation analysis for microarray and RNA-Seq data
Hänzelmann, S., Castelo, R., & Guinney, J. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-7 · Cited by 15,440 · cited 1×
“To assess gene expression signatures and pathway activation, a non-parametric and unsupervised software algorithm called GSVA software in the R package 58 with the RNA-seq mode was used.”
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R., Garimella, K. V., Maguire, J. R., Hartl, C., Philippakis, A. A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,456
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778 · cited 1×
“To further delineate the identity of carcinoma and non-carcinoma cells, we analysed the expression of tumour-associated stromal or immune gene sets proposed in the tumour purity estimation, ESTIMATE 26 .”
Cited by
Scenic: single-cell regulatory network inference and clustering.
Aibar, S., González-Blas, C. B., Moerman, T., Huynh-Thu, V. A., Imrichova, H., Hulselmans, G., Rambow, F., Marine, J.-C., Geurts, P., Aerts, J., et al. (2017) · Nature Methods · doi:10.1038/nmeth.4463 · Cited by 6,520
“57, 73 , Figure 3 and 6a ).”
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
“TAMs harbor highly plastic phenotypes and can be induced to polarize toward classically activated (M1) or alternatively activated (M2) phenotypes to exert immunostimulatory or immunosuppressive functions in tumor immunity.207,208 M1 macrophages exhibit a proinflammatory phenotype with tumor-killing capability, while M…”
BackgroundInfluentialMachine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., Kamińska, B., Huelsken, J., Omberg, L., Gevaert, O., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.034 · Cited by 2,180
“BRCA Single Cell RNA expression (Chung et al., 2017) GEO: GSE75688”
BackgroundMethodSelf-citationLandscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Zhang, Q., He, Y., Luo, N., Patel, S. J., Han, Y., Gao, R., Modak, M., Carotta, S., Haslinger, C., Kind, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.003 · Cited by 1,624
Lei, X., Lei, Y., Li, J.-K., Du, W.-X., Li, R.-G., Yang, J., Li, J., Li, F., & Tan, H.-B. (2020) · Cancer Letters · doi:10.1016/j.canlet.2019.11.009 · Cited by 1,470
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
“Recent work describes the use of these technologies to obtain an in-depth characterization of tumor ecosystems in different cancer types, including breast cancer (Chung et al., 2017), RCC (Chevrier et al., 2017), NSCLC (Lavin et al., 2017), and HCC (Zheng et al., 2017).”
BackgroundKim, N., Kim, H. K., Lee, K., Hong, Y., Cho, J. H., Choi, J. W., Lee, J.-I., Suh, Y.-L., Ku, B. M., Eum, H. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16164-1 · Cited by 1,274
Self-citationSingle‐cell RNA sequencing technologies and applications: A brief overview
Jovic, D., Liang, X., Zeng, H., Lin, L., Xu, F., & Luo, Y. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.694 · Cited by 1,271
Moncada, R., Barkley, D., Wagner, F., Chiodin, M., Devlin, J. C., Baron, M., Hajdu, C. H., Simeone, D. M., & Yanai, I. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0392-8 · Cited by 1,045
Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer.
Kieffer, Y., Hocine, H. R., Gentric, G., Pelon, F., Bernard, C., Bourachot, B., Lameiras, S., Albergante, L., Bonneau, C., Guyard, A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-1384 · Cited by 910
“In recent years, scRNA-seq appeared as a revolutionary technic for addressing intra-tumor cellular complexity (27,30,34-44).”
BackgroundA Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer
Wagner, J., Rapsomaniki, M. A., Chevrier, S., Anzeneder, T., Langwieder, C., Dykgers, A., Rees, M., Ramaswamy, A., Muenst, S., Soysal, S. D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.005 · Cited by 790
Deciphering breast cancer: from biology to the clinic
Nolan, E., Lindeman, G. J., & Visvader, J. E. (2023) · Cell · doi:10.1016/j.cell.2023.01.040 · Cited by 730
Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing
Maynard, A., McCoach, C. E., Rotow, J. K., Harris, L., Haderk, F., Kerr, D. L., Yu, E. A., Schenk, E. L., Tan, W., Zee, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.017 · Cited by 685
Zhou, Y., Yang, D., Yang, Q., Lv, X., Huang, W., Zhou, Z., Wang, Y., Zhang, Z., Yuan, T., Ding, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20059-6 · Cited by 672
Single-cell RNA sequencing for the study of development, physiology and disease
Potter, S. S. (2018) · Nature Reviews Nephrology · doi:10.1038/s41581-018-0021-7 · Cited by 622
Classification of triple-negative breast cancers based on Immunogenomic profiling
He, Y., Jiang, Z., Chen, C., & Wang, X. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-1002-1 · Cited by 624
Tumour heterogeneity and metastasis at single-cell resolution
Lawson, D. A., Kessenbrock, K., Davis, R. T., Pervolarakis, N., & Werb, Z. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0236-7 · Cited by 606
Cancer Stem Cells: The Architects of the Tumor Ecosystem
Prager, B. C., Xie, Q., Bao, S., & Rich, J. N. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2018.12.009 · Cited by 587
“Single-cell sequencing efforts and multiregional tumor studies have identified significant intratumoral diversity (Chung et al., 2017; Li et al., 2007; Puram et al., 2017).”
BackgroundMetabolic landscape of the tumor microenvironment at single cell resolution
Xiao, Z., Dai, Z., & Locasale, J. W. (2019) · Nature Communications · doi:10.1038/s41467-019-11738-0 · Cited by 524
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
The Need for Multi-Omics Biomarker Signatures in Precision Medicine
Olivier, M., Asmis, R., Hawkins, G. A., Howard, T. D., & Cox, L. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194781 · Cited by 499
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity
Kinker, G. S., Greenwald, A. C., Tal, R., Orlova, Z., Cuoco, M. S., McFarland, J. M., Warren, A., Rodman, C., Roth, J. A., Bender, S. A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-020-00726-6 · Cited by 445
Karaayvaz, M., Cristea, S., Gillespie, S. M., Patel, A. P., Mylvaganam, R., Luo, C. C., Specht, M. C., Bernstein, B. E., Michor, F., & Ellisen, L. W. (2018) · Nature Communications · doi:10.1038/s41467-018-06052-0 · Cited by 476
Pal, B., Chen, Y., Vaillant, F., Capaldo, B. D., Joyce, R., Song, X., Bryant, V. L., Penington, J. S., Di Stefano, L., Tubau Ribera, N., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020107333 · Cited by 469
“Emerging data from single-cell genomics indicate significant tumor heterogeneity, while single-cell transcriptomic profiling of breast tumors indicates diverse immune cell populations (Chung et al, 2017; Azizi et al, 2018; Karaayvaz et al, 2018; Kim et al, 2018; Savas et al, 2018; Qian et al, 2020).”
scGNN is a novel graph neural network framework for single-cell RNA-Seq analyses
Wang, J., Ma, A., Chang, Y., Gong, J., Jiang, Y., Qi, R., Wang, C., Fu, H., Ma, Q., & Xu, D. (2021) · Nature Communications · doi:10.1038/s41467-021-22197-x · Cited by 457
Chan, J. M., Quintanal-Villalonga, Á., Gao, V. R., Xie, Y., Allaj, V., Chaudhary, O., Masilionis, I., Egger, J., Chow, A., Walle, T., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.09.008 · Cited by 434
Zou, Y., Xie, J., Zheng, S., Liu, W., Tang, Y., Tian, W., Deng, X., Wu, L., Zhang, Y., Wong, C.-W., et al. (2022) · International Journal of Surgery · doi:10.1016/j.ijsu.2022.106936 · Cited by 426
Andersson, A., Larsson, L., Stenbeck, L., Salmén, F., Ehinger, A., Wu, S. Z., Al-Eryani, G., Roden, D., Swarbrick, A., Borg, Å., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26271-2 · Cited by 404
Single‐cell RNA sequencing in cancer research
Zhang, Y., Wang, D., Peng, M., Tang, L., Ouyang, J., Xiong, F., Guo, C., Tang, Y., Zhou, Y., Liao, Q., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01874-1 · Cited by 390
“This suggested that scRNA-seq could find important cell subsets, and might be used as an effective means to develop more effective targeted therapy for tumor types that are not sensitive to immunotherapy, such as triple negative breast cancer [94].”
BackgroundRoles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
Zhang, H., Liu, L., Liu, J., Dang, P., Hu, S., Yuan, W., Sun, Z., Liu, Y., & Wang, C. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01725-x · Cited by 389
“Single-cell transcriptome analysis of tumor tissue allows the characterization of heterogeneous tumor cells, adjacent stromal cells, and immune cells [102].”
BackgroundSingle-Cell Transcriptomics Meets Lineage Tracing
Kester, L., & van Oudenaarden, A. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2018.04.014 · Cited by 375
Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment
Ren, X., Zhang, L., Zhang, Y., Li, Z., Siemers, N., & Zhang, Z. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-110519-071134 · Cited by 370
Hu, Z., Li, Z., Ma, Z., & Curtis, C. (2020) · Nature Genetics · doi:10.1038/s41588-020-0628-z · Cited by 374
Mapping the immune environment in clear cell renal carcinoma by single-cell genomics
Borcherding, N., Vishwakarma, A., Voigt, A. P., Bellizzi, A., Kaplan, J., Nepple, K., Salem, A. K., Jenkins, R. W., Zakharia, Y., & Zhang, W. (2021) · Communications Biology · doi:10.1038/s42003-020-01625-6 · Cited by 364
Expression profile of immune checkpoint genes and their roles in predicting immunotherapy response
Hu, F.-F., Liu, C.-J., Liu, L.-L., Zhang, Q., & Guo, A.-Y. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa176 · Cited by 354
Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages
Obradovic, A., Chowdhury, N., Haake, S. M., Ager, C., Wang, V., Vlahos, L., Guo, X. V., Aggen, D. H., Rathmell, W. K., Jonasch, E., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.038 · Cited by 349
Roles of macrophages in tumor development: a spatiotemporal perspective
Bied, M., Ho, W. W., Ginhoux, F., & Blériot, C. (2023) · Cellular & Molecular Immunology · doi:10.1038/s41423-023-01061-6 · Cited by 345
Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians
Hashimoto, K., Kouno, T., Ikawa, T., Hayatsu, N., Miyajima, Y., Yabukami, H., Terooatea, T., Sasaki, T., Suzuki, T., Valentine, M., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1907883116 · Cited by 343
“These methods have been applied to various subjects such as finding signatures of aging in the human pancreas (22), observing infiltrating T cells in tumors (23, 24), and characterizing diversity of cell types during brain development (25).”
MethodElucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways
Jia, D., Lu, M., Jung, K. H., Park, J. H., Yu, L., Onuchic, J. N., Kaipparettu, B. A., & Levine, H. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816391116 · Cited by 336
“We looked into the single-cell RNA-seq data of 317 BC cells (40), which are classified into a W/O cluster and a low-low cluster (Fig.”
MethodBreast cancer heterogeneity and its implication in personalized precision therapy
Guo, L., Kong, D., Liu, J., Zhan, L., Luo, L., Zheng, W., Zheng, Q., Chen, C., & Sun, S. (2023) · Experimental Hematology & Oncology · doi:10.1186/s40164-022-00363-1 · Cited by 327
“At the transcriptomic level, single-cell RNA sequencing (scRNA-seq) involves the capture of mRNA from compartmentalized cells, reverse transcription into cDNA, amplification, and identification by oligomeric indexes and molecular markers enabling high-throughput analysis of transcriptome [203]; scRNA-seq has been used…”
MethodAdvancing Cancer Research and Medicine with Single-Cell Genomics
Lim, B., Lin, Y., & Navin, N. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.008 · Cited by 302
Macrophages: The Road Less Traveled, Changing Anticancer Therapy
Guerriero, J. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.03.006 · Cited by 293
Cui Zhou, D., Jayasinghe, R. G., Chen, S., Herndon, J. M., Iglesia, M. D., Navale, P., Wendl, M. C., Caravan, W., Sato, K., Storrs, E., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01157-1 · Cited by 284
Wu, L., Jin, Y., Zhao, X., Tang, K., Zhao, Y., Tong, L., Yu, X., Xiong, K., Luo, C., Zhu, J., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.001 · Cited by 284
CHETAH: a selective, hierarchical cell type identification method for single-cell RNA sequencing
de Kanter, J. K., Lijnzaad, P., Candelli, T., Margaritis, T., & Holstege, F. C. P. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz543 · Cited by 285
“, consists of a combination of datasets of Colorectal (35), Breast (36), Melanoma (24) and Head-Neck tumors (25).”
Song, H., Weinstein, H. N. W., Allegakoen, P., Wadsworth, M. H., Xie, J., Yang, H., Castro, E. A., Lu, K. L., Stohr, B. A., Feng, F. Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27322-4 · Cited by 279
Machine learning and statistical methods for clustering single-cell RNA-sequencing data
Petegrosso, R., Li, Z., & Kuang, R. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz063 · Cited by 281
Single-cell sequencing techniques from individual to multiomics analyses
Kashima, Y., Sakamoto, Y., Kaneko, K., Seki, M., Suzuki, Y., & Suzuki, A. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00499-2 · Cited by 270
El Bairi, K., Haynes, H. R., Blackley, E., Fineberg, S., Shear, J., Turner, S., de Freitas, J. R., Sur, D., Amendola, L. C., Gharib, M., et al. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00346-1 · Cited by 268
Ding, S., Chen, X., & Shen, K. (2020) · Cancer Communications · doi:10.1002/cac2.12078 · Cited by 255
“Korean researchers [13] conducted transcriptome analysis of 515 single cells from 11 patients with different breast cancer subtypes, including luminal A, luminal B, human epidermal growth factor receptor 2 (HER2), and TNBC.”
BackgroundTumor immune microenvironment lncRNAs
Park, E.-G., Pyo, S.-J., Cui, Y., Yoon, S.-H., & Nam, J.-W. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab504 · Cited by 251
“Picelli S, Faridani OR, Björklund ÅK, et al. Full-length RNA-seq from single cells using Smart-seq2.”
Advances in Biosensors and Diagnostic Technologies Using Nanostructures and Nanomaterials
Welch, E. C., Powell, J. M., Clevinger, T. B., Fairman, A. E., & Shukla, A. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202104126 · Cited by 240
Fan, J., Lee, H.-O., Lee, S., Ryu, D.-E., Lee, S., Xue, C., Kim, S. J., Kim, K., Barkas, N., Park, P. J., et al. (2018) · Genome Research · doi:10.1101/gr.228080.117 · Cited by 237
“Bulk K562 data (Deng et al. 2011) was downloaded from the Sequence Read Archive (accession number SRR315337) using SRAToolkit v2.”
Self-citationChe, L.-H., Liu, J.-W., Huo, J.-P., Luo, R., Xu, R.-M., He, C., Li, Y.-Q., Zhou, A.-J., Huang, P., Chen, Y.-Y., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00312-y · Cited by 222
Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
Dong, B., Miao, J., Wang, Y., Luo, W., Ji, Z., Lai, H., Zhang, M., Cheng, X., Wang, J., Fang, Y., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01476-1 · Cited by 218
Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis
Wang, G., Qiu, M., Xing, X., Zhou, J., Yao, H., Li, M., Yin, R., Hou, Y., Li, Y., Pan, S., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abk2756 · Cited by 218
The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes
Onkar, S. S., Carleton, N. M., Lucas, P. C., Bruno, T. C., Lee, A. V., Vignali, D. A. A., & Oesterreich, S. (2023) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0475 · Cited by 213
Comparison of glioblastoma (GBM) molecular classification methods
Lee, E., Yong, R. L., Paddison, P., & Zhu, J. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.07.006 · Cited by 213
Gomez-Roca, C. A., Italiano, A., Le Tourneau, C., Cassier, P. A., Toulmonde, M., D’Angelo, S. P., Campone, M., Weber, K. L., Loirat, D., Cannarile, M. A., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz163 · Cited by 213
“We also compared the PD changes in gene expression with published treatment-agnostic TAM signatures derived from single cell sequencing studies of metastatic melanoma [19], nonsmall-cell lung cancer [20] and breast cancer [21].”
BackgroundResultAsleh, K., Riaz, N., & Nielsen, T. O. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02476-1 · Cited by 209
“performed single-cell RNAsequencing (scRNA-seq) on 515 cells from 11 breast cancer patients and found that carcinoma cells displayed intratumoral heterogeneity regarding breast cancer subtypes and signalling pathways, while non-cancer cells were mostly immune cells that displayed 3 different clusters of T lymphocytes,…”
Understanding tumor ecosystems by single-cell sequencing: promises and limitations
Ren, X., Kang, B., & Zhang, Z. (2018) · Genome Biology · doi:10.1186/s13059-018-1593-z · Cited by 209
Roux, C., Jafari, S. M., Shinde, R., Duncan, G., Cescon, D. W., Silvester, J., Chu, M. F., Hodgson, K., Berger, T., Wakeham, A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819473116 · Cited by 207
“In these datasets, we looked for correlation between expression signature of human BC-infiltrating TAMs (48, 49), our key genes of interest (i.e., PD-L1 and NFKB1/p65) and a comprehensive ROS-induced gene signature (50).”
BackgroundIf we build it they will come: targeting the immune response to breast cancer
Gatti-Mays, M. E., Balko, J. M., Gameiro, S. R., Bear, H. D., Prabhakaran, S., Fukui, J., Disis, M. L., Nanda, R., Gulley, J. L., Kalinsky, K., et al. (2019) · npj Breast Cancer · doi:10.1038/s41523-019-0133-7 · Cited by 207
Spatial biology of cancer evolution
Seferbekova, Z., Lomakin, A., Yates, L. R., & Gerstung, M. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-022-00553-x · Cited by 203
Hu, Q., Hong, Y., Qi, P., Lu, G., Mai, X., Xu, S., He, X., Guo, Y., Gao, L., Jing, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22300-2 · Cited by 201
Single-Cell Transcriptomics: A High-Resolution Avenue for Plant Functional Genomics
Rich-Griffin, C., Stechemesser, A., Finch, J., Lucas, E., Ott, S., & Schäfer, P. (2020) · Trends in Plant Science · doi:10.1016/j.tplants.2019.10.008 · Cited by 198
“, healthy vs diseased/ cancerous tissue) [54].”
Januškevičienė, I., & Petrikaitė, V. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117009 · Cited by 196
Olbrecht, S., Busschaert, P., Qian, J., Vanderstichele, A., Loverix, L., Van Gorp, T., Van Nieuwenhuysen, E., Han, S., Van den Broeck, A., Coosemans, A., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00922-x · Cited by 192
Single-cell transcriptomics in cancer: computational challenges and opportunities
Fan, J., Slowikowski, K., & Zhang, F. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0422-0 · Cited by 191
Tumor Abnormality-Oriented Nanomedicine Design
Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 188
Nixon, B. G., Kuo, F., Ji, L., Liu, M., Capistrano, K., Do, M., Franklin, R. A., Wu, X., Kansler, E. R., Srivastava, R. M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.002 · Cited by 187
Gomes-Santos, I. L., Amoozgar, Z., Kumar, A. S., Ho, W. W., Roh, K., Talele, N. P., Curtis, H., Kawaguchi, K., Jain, R. K., & Fukumura, D. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0499 · Cited by 181
“Limited T-cell recruitment and function in the TME correlate with poor prognosis in breast cancer (21, 22).”
BackgroundDong, J., Hu, Y., Fan, X., Wu, X., Mao, Y., Hu, B., Guo, H., Wen, L., & Tang, F. (2018) · Genome Biology · doi:10.1186/s13059-018-1416-2 · Cited by 187
“c Scatterplots showing the expression of representative markers in two carcinoma datasets [32, 33].”
BackgroundMethodRicketts, T. D., Prieto-Dominguez, N., Gowda, P. S., & Ubil, E. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.642285 · Cited by 179
Lee, H. W., Chung, W., Lee, H.-O., Jeong, D. E., Jo, A., Lim, J. E., Hong, J. H., Nam, D.-H., Jeong, B. C., Park, S. H., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00741-6 · Cited by 183
Self-citationSanchez, A., Furberg, H., Kuo, F., Vuong, L., Ged, Y., Patil, S., Ostrovnaya, I., Petruzella, S., Reising, A., Patel, P., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30797-1 · Cited by 181
High-Throughput Methods in the Discovery and Study of Biomaterials and Materiobiology
Yang, L., Pijuan-Galito, S., Rho, H. S., Vasilevich, A. S., Eren, A. D., Ge, L., Habibović, P., Alexander, M. R., de Boer, J., Carlier, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00752 · Cited by 180
The B-Side of Cancer Immunity: The Underrated Tune
Largeot, A., Pagano, G., Gonder, S., Moussay, E., & Paggetti, J. (2019) · Cells · doi:10.3390/cells8050449 · Cited by 180
Xu, Y., Su, G.-H., Ma, D., Xiao, Y., Shao, Z.-M., & Jiang, Y.-Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00729-7 · Cited by 163
The Immunology of Hormone Receptor Positive Breast Cancer
Goldberg, J., Pastorello, R. G., Vallius, T., Davis, J., Cui, Y. X., Agudo, J., Waks, A. G., Keenan, T., McAllister, S. S., Tolaney, S. M., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.674192 · Cited by 171
“HR+ breast cancer is generally a more indolent breast cancer subtype, has a low TMB and low PD-L1 expression (9, 18).”
BackgroundSCSA: A Cell Type Annotation Tool for Single-Cell RNA-seq Data
Cao, Y., Wang, X., & Peng, G. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00490 · Cited by 167
“, 2018) and tumor (Chung et al., 2017), which have greatly promoted our understanding of human development and diseases.”
BackgroundMethodBao, X., Shi, R., Zhao, T., Wang, Y., Anastasov, N., Rosemann, M., & Fang, W. J. (2020) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02669-7 · Cited by 168
“Spearman’s coefficient analysis was performed to explore the correlation between EMT, angiogenesis, and stemness [2].”
BackgroundMethodHeterogeneity within molecular subtypes of breast cancer
Turner, K. M., Yeo, S. K., Holm, T. M., Shaughnessy, E., & Guan, J. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00109.2021 · Cited by 195
Harmancı, A. S., Harmanci, A. O., & Zhou, X. (2020) · Nature Communications · doi:10.1038/s41467-019-13779-x · Cited by 166
“For each SNP, we report the total count of reads supporting non-reference and reference nucleotide after applying the following filters: (1) reads should have mapping quality of at least 50, (2) minimum number of total reads per each SNP position should be 20, (3) minimum number of total reads supporting SNP should be…”
MethodHigh-throughput single-сell sequencing in cancer research
Jia, Q., Chu, H., Jin, Z., Long, H., & Zhu, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00990-4 · Cited by 175
“A previous study of primary breast cancer grouped 175 immune cells into three clusters: T cells, B cells, and M2 macrophages, all exhibiting an immunosuppressive phenotype.(146) In contrast, Azizi et al.”
BackgroundGlobal computational alignment of tumor and cell line transcriptional profiles
Warren, A. C., Chen, Y., Jones, A., Shibue, T., Hahn, W. C., Boehm, J. S., Vázquez, F., Tsherniak, A., & McFarland, J. M. (2021) · Nature Communications · doi:10.1038/s41467-020-20294-x · Cited by 174
Dissecting Tumor Growth: The Role of Cancer Stem Cells in Drug Resistance and Recurrence
Aramini, B., Masciale, V., Grisendi, G., Bertolini, F., Maur, M., Guaitoli, G., Isca, C., Morandi, U., Stella, F., Dominici, M., et al. (2022) · Cancers · doi:10.3390/cancers14040976 · Cited by 157
“Single-cell sequencing efforts and multiregional tumor studies have defined the compositions of different intratumoral cells [134].”
BackgroundGeldhof, V., de Rooij, L. P. M. H., Sokol, L., Amersfoort, J., Schepper, M. D., Rohlenová, K., Hoste, G., Vanderstichele, A., Delsupehe, A.-M., Isnaldi, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33052-y · Cited by 162
Zhang, M., Liu, Z. Z., Aoshima, K., Cai, W. L., Sun, H., Xu, T., Zhang, Y., An, Y., Chen, J. F.-Y., Chan, L.-H., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abf5473 · Cited by 155
“These cytokines also function in a paracrine fashion to recruit M2 TAMs (62), which are usually found in an immunosuppressive tumor microenvironment and support cancer cells to metastasize to distant organs (13, 63).”
BackgroundTumor intrinsic and extrinsic immune functions of CD155
O’Donnell, J. S., Madore, J., Li, X.-Y., & Smyth, M. J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.11.013 · Cited by 151
A gene regulatory network to control EMT programs in development and disease
Fazilaty, H., Rago, L., Youssef, K. K., Ocaña, O. H., García-Asencio, F., Arcas, A., Galcerán, J., & Nieto, M. A. (2019) · Nature Communications · doi:10.1038/s41467-019-13091-8 · Cited by 148
Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment
Pasha, N., & Turner, N. C. (2021) · Nature Cancer · doi:10.1038/s43018-021-00229-1 · Cited by 142
Next frontier in tumor immunotherapy: macrophage-mediated immune evasion
Qiu, Y., Chen, T., Hu, R., Zhu, R., Li, C., Ruan, Y., Xie, X., & Li, Y. (2021) · Biomarker Research · doi:10.1186/s40364-021-00327-3 · Cited by 153
Li, P., Kong, X., He, Y., Liu, Y., Peng, X., Li, Z., Xu, H. Y., Luo, H., & Park, J. (2022) · Military Medical Research · doi:10.1186/s40779-022-00414-y · Cited by 163
“Furthermore, scRNA-seq of breast cancer indicated that the angiogenesis factors plasminogen activator, urokinase receptor (PLAUR) and IL-8 were expressed in TAMs in addition to M2-type genes, such as CD163, membrane spanning 4-domains A6A (MS4A6A), and transforming growth factor beta-1 (TGF-β1) [113].”
Manifold learning-based methods for analyzing single-cell RNA-sequencing data
Moon, K. R., Stanley, J. S., Burkhardt, D. B., van Dijk, D., Wolf, G., & Krishnaswamy, S. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.12.008 · Cited by 174
Tuning the Tumor Myeloid Microenvironment to Fight Cancer
Jahchan, N. S., Mujal, A. M., Pollack, J. L., Binnewies, M., Sriram, V., Reyno, L. M., & Krummel, M. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01611 · Cited by 129
Identification of the novel exhausted T cell CD8 + markers in breast cancer
Liu, H., Dong, A., Rasteh, A. M., Wang, P., & Weng, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-70184-1 · Cited by 135
Chen, Y., Tan, W., & Wang, C. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s168317 · Cited by 131
Changing Technologies of RNA Sequencing and Their Applications in Clinical Oncology
Wang, Y., Mashock, M. J., Tong, Z., Mu, X., Chen, H., Zhou, X., Zhang, H., Zhao, G., Liu, B., & Li, X. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00447 · Cited by 142
Metadata
- Authors
- Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., Kan, Z., Han, W., & Park, W.-Y.
- Affiliations
- Samsung Medical Center (KR)
- Seoul National University (KR)
- Pfizer (United States) (US)
- Corresponding author
- Han, Wonshik
- Park, Woong-Yang
- ORCID
- Venue
- Nature Communications
- Published
- 2017-05-05
- Volume
- 8
- Issue
- 1
- Pages
- 15081-15081
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC5424158
- OpenAlex
- W2610509384
- Cited by
- 992
- References
- 62
- Citations by year
- 2026: 57 · 2025: 85 · 2024: 116 · 2023: 117 · 2022: 148 · 2021: 191 · 2020: 106 · 2019: 93 · 2018: 63 · 2017: 11
- FWCI
- 30.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2015R1A2A2A01008264, 2016R1A5A1011974)
- Samsung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- breast cancer, intratumoral heterogeneity, tumor immune microenvironment, tumor stroma, T cells, B cells, macrophages, regulatory T cells, T cell exhaustion, M2 macrophages, tumor subtypes, tumor transcriptome, copy number variation
- MeSH terms
- Exome Sequencing, B-Lymphocytes, Breast Neoplasms, Female, Humans, Lymph Nodes, Macrophages, Receptors, Estrogen, Receptors, Progesterone, T-Lymphocytes, Lymphocytes, Tumor-Infiltrating, Sequence Analysis, RNA, Carcinoma, Ductal, Breast, Erb-b2 Receptor Tyrosine Kinases, Receptor, ErbB-2, Gene Expression Profiling, DNA Copy Number Variations, Single-Cell Analysis, Tumor Microenvironment, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.